Cardinal Health's second-quarter fiscal 2025 results benefit from solid Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

View Cardinal Health, Inc. (CAH) current and estimated P/E ratio data provided by Seeking Alpha.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

According to the average brokerage recommendation (ABR), one should invest in Cardinal (CAH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Mizuho Securities analyst Steven Valiquette has maintained their bullish stance on CAH stock, giving a Buy rating on January 10. Discover outperforming stocks and invest smarter with Top Smart ...

Many Cardinal Health, Inc. ( NYSE:CAH ) insiders ditched their stock over the past year, which may be of interest ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) yesterday and set a price target of $145.00. Discover outperforming stocks and ...